10-DAY NCLEX REVIEW COURSE
DESCRIPTION: This 10-Day review course focuses on the core concepts that are commonly asked in the actual NCLEX. This course puts a lot of emphasis on critical thinking and technical drills designed to master Select-All-That-Apply (SATA), Drag and Drop, Exhibit/Graphic, Prioritization, and Delegation questions.
COURSE INCLUSIONS: 80 Hour Live/Webinar Course, Pre-Live Course Refresher Modules (online), Live Course Modules (downloadable for online), Assessment Exams, Practice NCLEX Questions and MORE!
DURATION: 10 Days, 80 Hours, Monday to Friday, 8 Hours/Day, 9AM to 6PM
*currently offered as a webinar course only, no onsite schedules available
FINAL COACHING PROGRAM
(NCLEX, HAAD, DHA, Prometric-RN)
DESCRIPTION: This 10-Day Integrated Final Coaching Program focuses on vital nursing concepts that are commonly asked in the actual exam that is supplemented by critical thinking activities and test-taking strategies / techniques.
COURSE INCLUSIONS: 10 days of salient points and critical thinking topics useful for ALL examinations (NCLEX, HAAD, DHA, Prometric-RN), up-to-date and well-researched "easy to remember" concepts, live Q&A with rationalizations, Assessment Examinations to assess your readiness in taking the actual examination, Free Online Practice Tests as a supplement to enhance learning
DURATION: 10 Days, 80 Hours, Monday to Friday, 8 Hours/Day, 9AM to 6PM
25-DAY LIVE NCLEX AND UK-CBT REVIEW COURSE
DESCRIPTION: The 25-Day Program is a comprehensive review course that covers ALL Core Content, Test Taking Strategies and Practice Questions in an in-depth manner. This course puts a lot of emphasis on critical thinking and technical drills designed to master Select-All-That-Apply (SATA), Drag and Drop, Exhibit/Graphic and Prioritization and Delegation questions. This course is best for students who have graduated several years ago or need a complete refresher on nursing concepts.
COURSE INCLUSION: 200-Hour Live Course, Pre-Live Modules (online), Pre- and Post-Assessment Tests, Live Course Modules, Online assignments, Comprehensive Exams, one-on-one evaluation, and Online NCLEX Practice Tests.
OPTIONAL: After the 25-day program, you have the option to continue to the 10-day Final Coaching program which focuses on discussion of NCLEX-type questions. This is a great way to apply what you have learned in the 25-day course.
DURATION: 25 Days, Monday to Friday, 8 Hours/Day, 9AM to 6PM
Frequently Asked Questions
The program runs over 5 – 6 years beginning in 2021:
Year 1: Pre-PhD start year of the program – 80% clinical (vocational) training / 20% PhD preparation
Years 2 – 4: PhD scholarship (2022 – 2024) – 80% PhD / 20% clinical role
Year 5: Post-PhD: 80% clinical (vocational) training / 20% preparation for post-doctoral fellowship application
Years 6 and 6+: As for Year 5 to completion of clinical (vocational) training and, ideally, a post-doctoral fellowship.
Eligible Study Areas
Any Australian Medical Council accredited specialist medical college training program leading to fellowship of the specialist medical college.
- Satellite imaging to transform detection of diabetic retinopathy and other retinal vascular diseases
- Repair of the cornea to restore vision: Translation to a Surgical Repair Device
- Neuronal responses to mitochondrial DNA haplogroups.
- Utilising technology to optimise the management of heart failure in primary care
- The clinical utility of pharmacogenomic testing to inform antidepressant prescribing in primary care.
- Investigating the Role of Epigenetics in Multiple Sclerosis
- Developing novel therapies to harness the progression of Multiple Sclerosis.
- Understanding disease mechanisms and outcomes in Australian children with acute stroke using sophisticated blood and neuroimaging biomarkers
- Taking placenta to scale: The population burden of disordered placentation and placental function
- Early life inflammation in non-communicable childhood disease.
- A tool for predicting prolonged grief in family carers of people living with dementia
- Identifying elder abuse in medical settings
- Enhancing 3D (dementia, delirium, depression) care for older people in residential care via micro-learning.
- Strategies to enhance the efficacy of targeted therapies in gastrointestinal cancers
- a) Improving tyrosine kinase inhibitors-based therapies for metastatic Her2+ breast cancer
b) Investigating the contribution of matrix/integrin signalling in breast cancer metastasis and therapy resistance
- a) Deploying novel technologies to identify resistance mechanisms in patients with haematological malignancies receiving targeted therapies
b) Identifying new strategies for minimum residual disease monitoring to optimise response assessment in myeloid & lymphoid malignancies.
- Understanding the behaviour of cancer at single cell resolution
- Improving management of infections in cancer
- Clinical investigation of the immune response to radiotherapy and immunotherapy.
- Translational research into haematological malignancies
- Utilising pre-clinical models to discover novel therapies for tuberculosis
- Hyposplenism in coeliac disease.
For more information about these specialisations, contact Senior Project Officer– Meredith Bickley
- The MACH-Track pathway is open to doctors training in any recognised medical specialty, including General Practice. Applicants should have won a place in a Melbourne-centred vocational training program approved by the relevant Royal/Specialist College; for specialties with two-stage programs (eg physicians) trainees should have secured a place in an advanced training program.
- Applicants must be currently in post in one of the ten MACH-affiliated health services, or be on a training rotation that will bring the candidate to a MACH-affiliated health service by February 2022. General Practice trainees will require sponsorship by the University of Melbourne Department of General Practice.
The selection committee will base its assessment on the application form, applicant career aspiration, CV and referee reports.
Applications should be sent to firstname.lastname@example.org and must include:
- A letter of application no longer than 500 words explaining why the applicant wants to pursue PhD training through the MACH-Track, to include broad areas of research interest;
- Brief details of the candidate’s vocational training program, with dates and location of each attachment; proposed end date; and details of the relevant College training committee including email contact for the lead College administrator;
- Full CV, to include details of any research experience and how findings were reported or disseminated (e.g. abstract presentation at meeting);
- A brief letter of support from an academic referee able to comment on the candidate’s potential for completing a PhD;
- A brief letter from the candidate’s current clinical training supervisor confirming that the candidate is making satisfactory progress in vocational training and stating support for the candidate seeking flexibility in clinical training, if appointed.
For General Practice trainees, a brief note from A/Prof Jo-Anne Manski-Nankervis confirming sponsorship by the University of Melbourne Department of General Practice.
Candidates short-listed for interview will be informed by 29th August 2020.
Short-listed trainees in hospital specialties will be required to provide by 27th September 2020 a brief letter of support signed by the CEO of the MACH-affiliated health service in which they would spend Year 1 of the Track confirming that they will be provided with an average of 8 hours per week research flexibility with no loss of earnings; a template will be provided.
Interviews will be held in the first two weeks of October 2020 ahead of a February 2021 start (the start date can be deferred to February 2022 to suit individuals.
12 August 2020 : Applications close at 5 PM (AEST) [deadline extended]
29 August 2020: Invitations sent out to short-listed candidates for interviews
27 September 2020: Short-listed trainees in hospital specialties are required to provide a brief letter of support signed by the CEO of the MACH-affiliated health service (template will be provided)
1 October – 14th October 2020 : Interviews are conducted
February 2021/February 2022 : Successful applicants to start their MACH-Track journey
MACH-Track Associate Directors
The MACH-Track Associate Directors are:
A/Prof Margie Danchin
MBBS PhD FRACP
Group Leader, Vaccine Uptake, Murdoch Children's Research Institute; Paediatrician, Department of General Medicine,The Royal Children's Hospital; A/Prof and David Bickart Clinician Scientist Fellow, Department of Paediatrics and School of Population and Global Health, The University of Melbourne; Director Clinician Scientist pathways, The University of Melbourne Chair, Collaboration on Social Science and Immunisation (COSSI).
Professor Mark Dawson
FAHMS MBBS; FRACP; FRCPA; PhD
Associate Director for Research Translation; Consultant Haematologist; Program Head, Cancer Biology & Therapeutics; Head, Cancer Epigenetics Laboratory, Peter MacCallum Cancer Centre.
Professor Kate Drummond AM
MBBS MD FRACS
Neurosurgeon; Director of Neurosurgery, RMH; Head of Central Nervous System Tumours, VCCC, Parkville Precinct.
Prof Hui K. Gan
MBBS, PhD, FRACP
Director, Cancer Clinical Trials Unit, Austin Health; Clinical Research Lead and Co-Director, Centre for Research Excellence in Brain Cancer Research, Olivia Newton-John Cancer Research Institute.
A/Prof Jo-Anne Manski-Nankervis
BSc(Hons) MBBS(Hons) CHIA PhD FRACGP
Academic General Practitioner and Lead, Data Driven Quality Improvement Research Theme, Department of General Practice, University of Melbourne; Chair, RACGP Expert Committee - Research.